Literature DB >> 912511

1alpha-Hydroxycholecalciferol in renal osteodystrophy.

A M Pierides, H A Ellis, M K Ward, W Simpson, D N Kerr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912511     DOI: 10.1007/bf02064049

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  12 in total

1.  The treatment of renal-glomerular osteodystrophy.

Authors:  C E DENT; C M HARPER; G R PHILPOT
Journal:  Q J Med       Date:  1961-01

2.  Bone histology in incipient and advanced renal failure.

Authors:  H H Malluche; E Ritz; H P Lange; L Kutschera; M Hodgson; U Seiffert; W Schoeppe
Journal:  Kidney Int       Date:  1976-04       Impact factor: 10.612

3.  Bone disease in long-term haemodialysis: the association of radiological with histological abnormalities.

Authors:  W Simpson; H A Ellis; D N Kerr; M McElroy; R A McNay; K N Ppeart
Journal:  Br J Radiol       Date:  1976-02       Impact factor: 3.039

4.  Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man.

Authors:  M Peacock; J C Gallagher; B E Nordin
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

5.  Quantitative observations on mineralized and non-mineralized bone in the iliac crest.

Authors:  H A Ellis; K M Peart
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

6.  Barbiturate and anticonvulsant treatment in relation to osteomalacia with haemodialysis and renal transplantation.

Authors:  A M Pierides; H A Ellis; M Ward; W Simpson; K M Peart; F Alvarez-ude; P R Uldall; D N Kerr
Journal:  Br Med J       Date:  1976-01-24

7.  1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.

Authors:  J C Chan; S B Oldham; M F Holick; H F DeLuca
Journal:  JAMA       Date:  1975-10-06       Impact factor: 56.272

8.  Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.

Authors:  A M Pierides; H A Ellis; W Simpson; J H Dewar; M K Ward; D N Kerr
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

9.  Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

Authors:  L Tougaard; E Sorensen; J Brochner-Mortensen; M S Christensen; P Rodbro; A W Sorensen
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

10.  Azotaemic renal osteodystrophy: a quantitative study on iliac bone.

Authors:  H A Ellis; K M Peart
Journal:  J Clin Pathol       Date:  1973-02       Impact factor: 3.411

View more
  2 in total

1.  Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.

Authors:  F U Eke; M H Winterborn
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

Review 2.  Pharmacology and therapeutic use of vitamin D and its analogues.

Authors:  A M Pierides
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.